2023 Fall Conference | C27 - Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD)

Date Sunday 10/29/23

Time 09:30 AM - 11:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brenda L. Banwell, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Participants should gain an understanding of the new international MOGAD diagnostic criteria and their application in clinical practice using both didactic and case examples; be able to illustrate key neuroimaging features of MOGAD; and discuss current therapies and future clinical trials for pediatric and adult MOGAD.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials

Event Timeline
09:30 AM - 09:35 AM PDT	Introduction	Welcome and Introduction Brenda L. Banwell, MD, FAAN
09:35 AM - 10:00 AM PDT	Speaker	MOGAD Diagnostic Criteria Giulia Fadda, MD
10:00 AM - 10:25 AM PDT	Speaker	Imaging Features of MOGAD and Differential Eoin P. Flanagan, MBBCh, FAAN
10:25 AM - 10:45 AM PDT	Speaker	Clinical Features and Management of MOGAD Brenda L. Banwell, MD, FAAN
10:50 AM - 11:00 AM PDT	Q&A	Question and Answers Brenda L. Banwell, MD, FAAN

Faculty Disclosures
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Giulia Fadda, MD	Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon Therapeutics. Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis.

��ɫ��

��ɫ��